Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Daiichi Sankyo
Mallinckrodt
Fuji
Cerilliant
Harvard Business School
Argus Health
Julphar

Generated: May 20, 2018

DrugPatentWatch Database Preview

VIROPTIC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Viroptic patents expire, and when can generic versions of Viroptic launch?

Viroptic is a drug marketed by Monarch Pharms and is included in one NDA.

The generic ingredient in VIROPTIC is trifluridine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the trifluridine profile page.
Drug patent expirations by year for VIROPTIC
Medical Subject Heading (MeSH) Categories for VIROPTIC
Synonyms for VIROPTIC
006T534
1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
1-((2R,5R)-4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-trifluoromethyl-1H-pyrimidine-2,4-dione
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
2 inverted exclamation marka-Deoxy-5-trifluoromethyluridine
2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-ribofuranosyl)-5-(trifluoromethyl)-
2'-Deoxy-5-(trifluoromethyl)uridine
2'-Deoxy-5-trifluoromethyluridine
5-(Trifluoromethyl)-2'-deoxyuridine
5-(Trifluoromethyl)deoxyuridine
5-Trifluoro-2'-deoxythymidine
5-Trifluoromethyl-2-deoxyuridine
5-Trifluoromethyl-2'-deoxyuridine
5-trifluoromethyl-2''-deoxyuridine
5-Trifluoromethylthymidine
5-Trifluorothymidine
70-00-8
AB0068586
AB2000289
AC1L1M4O
ACN-036847
AJ-45814
AK-24803
AKOS015919482
alpha,alpha,alpha-Trifluorothymidine
AM20100660
AN-11686
AX8011895
BDBM50132298
BR-24803
BRD-K03243820-001-12-1
BRN 0568095
C-18551
C10H11F3N2O5
CAS-70-00-8
CC-35357
CCG-221056
CCRIS 2348
CF3dUrd
CHEBI:75179
CHEMBL1129
cid_6256
cid_6708818
CS-1602
D00391
D05RHI
DB00432
DSSTox_CID_26602
DSSTox_GSID_46602
DSSTox_RID_81757
DTXSID4046602
EINECS 200-722-8
F3DThd
F3T
F3TDR
Fluridine
FT-0082240
GTPL8697
HMS2233N19
HS-0007
HY-A0061
J-700255
J-700357
KB-80814
KS-00000FU6
LS-153788
MFCD00006534
MLS000028361
MLS001148248
MLS006010219
MolPort-003-959-693
NCGC00166323-01
NCGC00166323-02
NSC 529182
NSC 75520
NSC529182
NSC75520
NUC0000876
Opera_ID_1810
PC2508
RMW9V5RW38
S-5386
S1778
SC-09179
SCHEMBL3479
SMR000058583
SR-01000721911
SR-01000721911-2
SRI-10817_14
SRI-10817-12
TFDU
Thymidine, alpha,alpha,alpha-trifluoro-
Tox21_112411
Tox21_112411_1
Trifluoridine
Trifluoromethyl Deoxyuridine
Trifluoromethyldeoxyuridine
TRIFLUOROTHYMIDINE
Trifluorothymidine, >=99% (HPLC)
Trifluorothymine deoxyriboside
Triflurdine (Viroptic)
Trifluridin
Trifluridina
Trifluridina [INN-Spanish]
Trifluridine
Trifluridine (JAN/USP/INN)
Trifluridine (USP/INN)
Trifluridine (Viroptic)
Trifluridine [USAN:INN]
Trifluridine [USAN:USP:INN]
Trifluridine, British Pharmacopoeia (BP) Reference Standard
Trifluridine, United States Pharmacopeia (USP) Reference Standard
Trifluridinum
Trifluridinum [INN-Latin]
UNII-RMW9V5RW38
Uridine, 2'-deoxy-5-(trifluoromethyl)-
Virophta
Viroptic (TN)
Viroptic, Trifluorothymidine, Trifluridine
Viroptic;Trifluorothymidine
VSQQQLOSPVPRAZ-RRKCRQDMSA-N
ZINC3842753

US Patents and Regulatory Information for VIROPTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms VIROPTIC trifluridine SOLUTION/DROPS;OPHTHALMIC 018299-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Merck
Boehringer Ingelheim
Dow
UBS
AstraZeneca
Cantor Fitzgerald
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.